| 3KM4: reference: Optimization of orally bioavailable alkyl amine renin inhibitors., Xu Z, Cacatian S, Yuan J, Simpson RD, Jia L, Zhao W, Tice CM, Flaherty PT, Guo J, Ishchenko A, Singh SB, Wu Z, McKeever BM, Scott BB, Bukhtiyarov Y, Berbaum J, Mason J, Panemangalore R, Cappiello MG, Bentley R, Doe CP, Harrison RK, McGeehan GM, Dillard LW, Baldwin JJ, Claremon DA, Bioorg Med Chem Lett. 2009 Dec 1. PMID: 19959358 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).